CLIA Chlamydia pneumoniae IgA
Chemiluminescence kit for the detection of IgA antibodies to Chlamydia pneumoniae in human serum or plasma
New
Chemiluminescence kit for the detection of IgA antibodies to Chlamydia pneumoniae in human serum or plasma
| Catalog Number: | CL-CPA100 |
|---|---|
| Size: | 100 tests |
| Regulatory status: | CE IVD |
| Clinical topic: | Infectious Diseases |
| Diagnostic panel: |
COVID-19 Respiratory Diseases |
Chlamydiae are gram-negative bacteria, obligate intracellular parasites. Among them, Chlamydia pneumoniae is the most widespread species in the human population and can cause respiratory tract infections, such as pneumonia. In recent years, the number of acute and chronic infections has increased. The Primary infection usually occurs between 5 and 18 years of age. The typical clinical symptoms include rhinitis, sinusitis, otitis media, pharyngitis, bronchitis, atypical pneumonia with non-productive cough and indistinctive auscultatory findings. In the past 20 years, researchers have linked a wide variety of diseases to C. pneumoniae infection.
| Assay stability | 30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C |
| Sample matrix | Serum, Plasma |
| Sample volume | 10 µL |
| Measuring range | 5 - 100 U/ml |
| Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |
| Complementary products | Wash buffer, Anchor® Tips, Stackable cuvettes, Trigger solutions |
| Note | The kits are CE-IVD certified and intended for professional use. |